Elevation Oncology Inc (NAS:ELEV)
$ 3.84 0.15 (4.07%) Market Cap: 209.81 Mil Enterprise Value: 136.57 Mil PE Ratio: 0 PB Ratio: 2.62 GF Score: 24/100

Elevation Oncology Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript

Feb 15, 2023 / 09:20PM GMT
Release Date Price: $0.98
Andrew Berens
SVB Securities - Analyst

Good afternoon, everyone. I'm Andrew Berens, senior biotech analyst at SVB Securities. Thank you for joining us on day three of our 12th Annual Global Healthcare Conference.

We're really excited today to have Elevation Oncology. We have the CEO, Joseph Ferra. And he'll be walking you through a presentation. (Conference Instructions)

So I'll hand off to you, Joe. Thanks for joining us today. Appreciate it.

Joseph Ferra
Elevation Oncology, Inc. - Interim CEO & CFO

Thank you, Andy. Appreciate it as well and thank you to the entire SVB team for hosting us. Good afternoon, everyone. As Andy said, Joe Ferra, Interim Chief Executive Officer and CFO of Elevation Oncology. I look forward to reviewing with you our corporate strategy. who we are as a company, and our focused on making a difference for patients who are suffering from cancer.

During this presentation, I'll be making some forward-looking statements. For complete review of our risk factors, please look at our website, as well as look

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot